GE HealthCare Introduces Advanced Combination Radiation Therapy Planning Software

GE HealthCare has introduced MIM ComboTherapy GYN HDR/EBRT, a radiation therapy planning solution developed to improve dose evaluation and treatment planning for gynecologic cancers. The software is designed for clinicians managing combination radiation therapies, particularly high-dose-rate (HDR) brachytherapy and external beam radiation therapy (EBRT), where cumulative dose assessment remains a significant technical challenge.

Gynecologic cancers such as cervical and uterine cancer are commonly treated using multimodal radiation therapy approaches. In these workflows, clinicians must evaluate the combined biological impact of radiation delivered across multiple treatment sessions and modalities while minimizing exposure to surrounding healthy tissue. Conventional planning methods have often relied on approximations when calculating cumulative dose distribution, particularly in anatomically complex cases.

3D Dose Summation for Combination Radiation Therapy
The MIM ComboTherapy GYN HDR/EBRT platform introduces advanced 3D dose summation capabilities designed to provide a more accurate representation of cumulative radiation exposure. The system incorporates Biological Effective Dose (BED) and Equivalent Dose in 2 Gy fractions (EQD2) calculations to evaluate the biological impact of combined therapies across patient anatomy.

The software enables clinicians to visualize dose accumulation areas, including high-dose “hotspots,” across both HDR brachytherapy and EBRT treatment plans. This allows more detailed analysis of dose overlap and organ-at-risk exposure during treatment planning and evaluation.

The platform also includes deformable image registration validation tools that support both qualitative and quantitative assessment of anatomical mapping accuracy. This functionality is particularly relevant in gynecologic oncology, where anatomical shifts caused by HDR applicators or treatment positioning can complicate spatial dose tracking between therapy sessions.

By integrating deformable registration with spatial dose mapping, the solution aims to improve confidence in cumulative dose assessment for complex combination therapies.

Integration Into Radiation Oncology Workflows
The technology forms part of the MIM Software portfolio within GE HealthCare’s radiation oncology ecosystem. The platform is designed to integrate into existing clinical workflows with vendor-neutral compatibility across treatment planning systems.

According to the company, the software includes standardized workflow automation features intended to streamline plan preparation while maintaining interoperability in mixed-vendor clinical environments. This approach may help reduce workflow fragmentation in radiation oncology departments managing multi-system treatment planning infrastructures.

Early clinical evaluations referenced by GE HealthCare indicate that advanced deformable registration and spatial dose accumulation methods can provide a clinically viable framework for assessing cumulative dose in gynecologic combination therapy cases.

The announcement coincides with Women’s Health Month and highlights the growing emphasis on personalized and data-driven oncology treatment planning in women’s healthcare. Approximately 100,000 women in the United States are diagnosed with gynecologic cancers each year, creating ongoing demand for treatment planning technologies that improve precision while supporting organ preservation and toxicity management.

Edited by Natania Lyngdoh, Induportals editor, with AI assistance.

www.gehealthcare.com